More trial data backs Merck's cervical cancer shot
16554
New data from a combined analysis of  four Phase II/III studies involving more than 20,000 women  confirm the effectiveness of Merck & Co Inc's cervical cancer  vaccine Gardasil, researchers said on Thursday.
58445
A vaccine may work to protect women against a virus that causes most cases of cervical cancer, US researchers reported on Monday. So far
551343
Years of clinical trials have yielded promising results for a vaccine that would protect women from a virus that causes cervical cancer.
527030
Drugmaker Merck & Co. Inc.   boosted its 2007 earnings forecast on Wednesday, citing  higher-than-expected sales of multiple products, including its  cancer vaccine Gardasil and diabetes drug Januvia.
519656
A lawyer who represents Merck & Co. in its litigation over Vioxx said on Tuesday that an unpublished study that reportedly shows heart risks with the withdrawn painkiller in short-term use is not supported by other data.
78721
Safe sex may prevent the growth of cervical and other cancers, according to researchers.
333108
Washington - A vaccine may work to protect women against a virus that causes most cases of cervical cancer, US researchers reported on Monday.
46908
A vaccine that prevents infections known to cause cervical cancer could be available to women within three years, UK experts believe.
209020
For the first time, scientists have proof that condoms offer women impressive protection against the virus that causes cervical cancer.
138871
We have today been informed of new clinical trial data for celecoxib (Celebrex), showing an increased risk of heart attack, stroke and death (relative to placebo).
740266
Washington - Years of clinical trials have yielded promising results for a vaccine that would protect women from a virus that causes cervical cancer, researchers said on Monday.
509725
A Merck vaccine, which makes people immune to a common sexually transmitted virus (human papilloma virus - HPV) which causes cervical cancer, seems to continue offering protection from cervical cancer two years after preliminary testing, say scientists at
37733
A vaccine developed to protect woman from a virus responsible for most cervical cancer cases has shown promising results in clinical trials.
439296
Drugmaker Merck & Co. Inc.  boosted its 2007 earnings forecast on Wednesday, citing higher-than-expected sales of multiple products, including its cancer vaccine Gardasil and diabetes drug Januvia.
80318
A drug company hopes to win federal approval early next month for a novel cervical cancer vaccine that it touts as the next biggest thing since the pap test in fighting the No. 2 cancer in women.
303689
Acorda announces positive clinical trial data.
266095
The pharmaceutical industry made a commitment Thursday to publish more data about clinical drug trials, amid growing questions about the safety of many leading companies' medicines.